|Articles|August 1, 2017
- Pharmaceutical Executive-08-01-2017
- Volume 37
- Issue 8
Pharmaceutical Executive, August 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 9 years ago
Health Policy Problem Solver: Fumie Griegoabout 9 years ago
Dealmaking in 2017: Striking a Balanceabout 9 years ago
Beyond the Science: Commercial Implications From ASCO 2017about 9 years ago
News Spotlight: Pharmaabout 9 years ago
Pharma’s Marijuana Makeoverabout 9 years ago
The 'Hear' and Now for Pharma and Social Mediaabout 9 years ago
Pressure Mounts on FDA, Pharma to Tackle Opioid Abuseabout 9 years ago
Syncing Social Media With Value-Care Modelabout 9 years ago
AI-based Social Listening as Aid to Pharmacovigilanceabout 9 years ago
Country Report: IndonesiaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
3
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5